Uses of novel fatty acid desaturases and elongases and products thereof
First Claim
1. Plant seed oil obtained from seeds of a transgenic plant, wherein the oil comprises at least 1% docosahexaenoic acid (DHA) and at least 1% but not more than 6% eicosapentaenoic acid (EPA), based on the total fatty acids of the transgenic seeds, and wherein the oil has a ratio of DHA to docosapentaenoic acid (DPA) of at least 2.
1 Assignment
1 Petition
Accused Products
Abstract
The invention provides isolated nucleic acid molecules which encode novel fatty acid desaturases and elongases from the organism Emiliana huxleyi. The invention also provides recombinant expression vectors containing desaturase or elongase nucleic acid molecules, host cells into which the expression vectors have been introduced, and methods for large-scale production of long chain polyunsaturated fatty acids (LCPUFAs), e.g. arachidonic acid (ARA), eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA).
6 Citations
17 Claims
- 1. Plant seed oil obtained from seeds of a transgenic plant, wherein the oil comprises at least 1% docosahexaenoic acid (DHA) and at least 1% but not more than 6% eicosapentaenoic acid (EPA), based on the total fatty acids of the transgenic seeds, and wherein the oil has a ratio of DHA to docosapentaenoic acid (DPA) of at least 2.
- 9. Plant seed oil obtained from seeds of a transgenic plant, wherein the oil comprises at least 1% docosahexaenoic acid (DHA) and at least 1% but not more than 6% eicosapentaenoic acid (EPA), based on the total fatty acids of the transgenic seed, and wherein the seeds of the transgenic plant have a conversion rate of docosapentaenoic acid (DPA) to DHA of at least 75%.
Specification